TNFRSF12A and prostate cancer: Since TWEAK treatment of glioma [62], prostate cancer [48] and melanoma [55] cells in vitro has been shown previously to increase Fn14 gene expression, we first analyzed Fn14 protein levels in the four B16 cell lines using Western blot analysis.